Drug Development

Opioid Overdose Reversal Hormone Injections Alzheimer's Treatment FDA Approval Clinical Trials Chemotherapy Tofersen GLP-1 Receptor Targeting Drugs Materials Science

FDA Encourages Lower Doses in Cancer Drug Testing

In response to patient and doctor concerns, the FDA urges more tolerable cancer treatments through Project Optimus.

Lack of Mandatory Obesity Drug Testing Raises Concerns Over Safety and Efficacy of Medications

FDA Approves New Powerful Nasal Spray to Reverse Opioid Overdoses